177 related articles for article (PubMed ID: 32726508)
1. Protective role of Astragaloside IV in chronic glomerulonephritis by activating autophagy through PI3K/AKT/AS160 pathway.
Lu R; Chen J; Liu B; Lin H; Bai L; Zhang P; Chen D; Li H; Li J; Pang Y; Zhou Y; Zhou J; Wu J
Phytother Res; 2020 Dec; 34(12):3236-3248. PubMed ID: 32726508
[TBL] [Abstract][Full Text] [Related]
2. Baicalin Reduces Renal Inflammation in Mesangial Proliferative Glomerulonephritis through Activation of Nrf2/ARE and PI3K/AKT Pathways.
Ning X; Luo D; Chen Y; Shao Y; Xu J
Discov Med; 2023 Jun; 35(176):372-382. PubMed ID: 37272104
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
[TBL] [Abstract][Full Text] [Related]
4. Salvianolic acid B attenuates membranous nephropathy by activating renal autophagy via microRNA-145-5p/phosphatidylinositol 3-kinase/AKT pathway.
Chen J; Hu Q; Luo Y; Luo L; Lin H; Chen D; Xu Y; Liu B; He Y; Liang C; Liu Y; Zhou J; Wu J
Bioengineered; 2022 May; 13(5):13956-13969. PubMed ID: 35723058
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV Mediates the PI3K/Akt/mTOR Pathway to Alleviate Injury and Modulate the Composition of Intestinal Flora in ApoE
Sun D; Wang Y; Pang B; Jiang L
Discov Med; 2024 May; 36(184):1070-1079. PubMed ID: 38798265
[TBL] [Abstract][Full Text] [Related]
6.
Chen Y; Zheng YF; Lin XH; Zhang JP; Lin F; Shi H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165163
[No Abstract] [Full Text] [Related]
7. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway.
Cheng S; Zhang X; Feng Q; Chen J; Shen L; Yu P; Yang L; Chen D; Zhang H; Sun W; Chen X
Life Sci; 2019 Jun; 227():82-93. PubMed ID: 31004658
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia-Reoxygenation.
Yang P; Zhou Y; Xia Q; Yao L; Chang X
Biol Pharm Bull; 2019 May; 42(5):721-727. PubMed ID: 30867343
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV improves renal function and alleviates renal damage and inflammation in rats with chronic glomerulonephritis.
Zhang D; Li Z; Gao Y; Sun H
Turk J Biol; 2023; 47(1):61-73. PubMed ID: 37529109
[TBL] [Abstract][Full Text] [Related]
11. Zhen-Wu-Tang Induced Mitophagy to Protect Mitochondrial Function in Chronic Glomerulonephritis via PI3K/AKT/mTOR and AMPK Pathways.
Liu B; Cao Y; Wang D; Zhou Y; Zhang P; Wu J; Chen J; Qiu J; Zhou J
Front Pharmacol; 2021; 12():777670. PubMed ID: 35757387
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury.
Tang JL; Xin M; Zhang LC
Aging (Albany NY); 2022 Jul; 14(14):5855-5877. PubMed ID: 35859295
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV, a saponin from Astragalus membranaceus var. mongholicus, induces expressions of heme recycle proteins via signaling of Nrf2/ARE in cultured macrophages.
Gong G; Yu H; Zheng Y; Qi B; He H; Yin T; Dong TT; Tsim KW
J Ethnopharmacol; 2021 Jan; 265():113389. PubMed ID: 32920134
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy.
Yin Y; Qu H; Yang Q; Fang Z; Gao R
Phytomedicine; 2021 Nov; 92():153749. PubMed ID: 34601220
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
Zhang J; Wu C; Gao L; Du G; Qin X
Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV Improves Vasodilatation Function by Regulating the PI3K/Akt/eNOS Signaling Pathway in Rat Aorta Endothelial Cells.
Lin XP; Cui HJ; Yang AL; Luo JK; Tang T
J Vasc Res; 2018; 55(3):169-176. PubMed ID: 29972829
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
[TBL] [Abstract][Full Text] [Related]
18. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
19. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.
Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L
PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1α accumulation via phosphatidylinositol 3-kinase/Akt pathway.
Zhang L; Liu Q; Lu L; Zhao X; Gao X; Wang Y
J Pharmacol Exp Ther; 2011 Aug; 338(2):485-91. PubMed ID: 21576377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
